![]() |
Volumn 4, Issue 3, 1999, Pages 151-156
|
Antiretroviral effect of two different dose regimens of ritonavir and saquinavir on HIV-infected adults in a population-based setting
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
DELAVIRDINE;
DIDANOSINE;
LAMIVUDINE;
NEVIRAPINE;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADULT;
ARTICLE;
CANADA;
CELL COUNT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEMALE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PARESTHESIA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
VIRUS LOAD;
VOMITING;
CD4 LYMPHOCYTE COUNT;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
IMMUNOLOGY;
MIDDLE AGED;
VIROLOGY;
ADULT;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
MIDDLE AGED;
RITONAVIR;
SAQUINAVIR;
VIRAL LOAD;
|
EID: 0032833783
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: 10.1177/135965359900400303 Document Type: Article |
Times cited : (1)
|
References (5)
|